Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Gain Therapeutics, Inc. Common Stock (GANX)

Pharmaceutical Preparations

https://www.gaintherapeutics.com

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements.

4800 HAMPDEN LANE, SUITE 200
BETHESDA, MD

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/18/2021

Market Cap

31,963,995

Shares Outstanding

20,460,000

Weighted SO

16,199,368

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

BIVI --.--%

INAB --.--%

NAMS --.--%

CUE --.--%

TFFP --.--%

LIFE --.--%

LTRN --.--%

ELYM --.--%

Beta

0.3460

Last Div

0.0000

Range

0.89-5.33

Chg

0.0400

Avg Vol

317041

Mkt Cap

31963995

Exch

NASDAQ

Country

US

Phone

301 500 1556

DCF Diff

0.6240

DCF

0.6560

Div Yield

0.0000

P/S

493.2715

EV Multiple

-0.7241

P/FV

2.0708

Div Yield %

0.0000

P/E

-1.1298

PEG

0.0727

Payout

0.0000

Current Ratio

2.8421

Quick Ratio

2.8421

Cash Ratio

2.5964

DSO

1764.4370

DIO

0.0000

Op Cycle

1764.4370

DPO

8766.7501

CCC

-7002.3131

Gross Margin

-0.3151

Op Margin

-337.2339

Pretax Margin

-332.4454

Net Margin

-333.3257

Eff Tax Rate

-0.0026

ROA

-1.1252

ROE

-2.1420

ROCE

-1.7243

NI/EBT

1.0026

EBT/EBIT

0.9858

EBIT/Rev

-337.2339

Debt Ratio

0.0351

D/E

0.0571

LT Debt/Cap

0.0309

Total Debt/Cap

0.0540

Int Coverage

143.7350

CF/Debt

-28.1769

Equity Multi

1.6289

Rec Turnover

0.2069

Pay Turnover

0.0416

Inv Turnover

0.0000

FA Turnover

0.1441

Asset Turnover

0.0034

OCF/Share

-0.9872

FCF/Share

-0.9884

Cash/Share

0.8814

OCF/Sales

-292.7481

FCF/OCF

1.0012

CF Coverage

-28.1769

ST Coverage

-63.6800

CapEx Coverage

-853.8927

Div&CapEx Cov

-853.8927

P/BV

2.0708

P/B

2.0708

P/S

493.2715

P/E

-1.1298

P/FCF

-1.6830

P/OCF

-1.2864

P/CF

-1.2864

PEG

0.0727

P/S

493.2715

EV Multiple

-0.7241

P/FV

2.0708

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jun 14, 01:00 Gain Therapeutics Announces Pricing of $11.0 Million Public Offering GlobeNewswire Inc. Nov 24, 13:01 Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option GlobeNewswire Inc. Nov 24, 13:01 Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option GlobeNewswire Inc. Nov 21, 08:54 Gain Therapeutics Announces Pricing of $9.4 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants

Revenue Product Segmentation